The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) in gastric cancer patients with stage III (POST trial).
Choong-kun Lee
No relevant relationships to disclose
Minkyu Jung
No relevant relationships to disclose
Seok Yun Kang
No relevant relationships to disclose
Bong-Seog Kim
No relevant relationships to disclose
Ki Hyang Kim
No relevant relationships to disclose
Kyung Hee Lee
No relevant relationships to disclose
Moon Hee Lee
No relevant relationships to disclose
Dong Bok Shin
No relevant relationships to disclose
Dae Young Zang
No relevant relationships to disclose
Ji Yeong Ahn
No relevant relationships to disclose
Hyoung-Il Kim
No relevant relationships to disclose
Woo Jin Hyung
No relevant relationships to disclose
Sung Hoon Noh
No relevant relationships to disclose
Hyo Song Kim
No relevant relationships to disclose
Hyun Cheol Chung
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose